TROW
47
-6
RHI
57
-6
OI
42
-3
COF
62
3
IBM
47
-3
WHR
65
-5
BMY
55
-8
LLY
28
-8
BBY
52
6
VRSK
68
-12
VRSN
53
-5
SJM
9
-5
PGR
59
-3
SLB
52
-3
FE
44
5
NVDA
52
-5
KEY
43
-3
OXY
36
-2
HRL
35
-3
SIG
44
-3
TROW
47
-6
RHI
57
-6
OI
42
-3
COF
62
3
IBM
47
-3
WHR
65
-5
BMY
55
-8
LLY
28
-8
BBY
52
6
VRSK
68
-12
VRSN
53
-5
SJM
9
-5
PGR
59
-3
SLB
52
-3
FE
44
5
NVDA
52
-5
KEY
43
-3
OXY
36
-2
HRL
35
-3
SIG
44
-3
Financhill
Back

TCW Flexible Income ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
22

FLXR
TCW Flexible Income ETF

Last Price:
38.76
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.89
Seasonality Move:
17.03%
Sell
22
TCW Flexible Income ETF (FLXR) is a Sell

Is TCW Flexible Income ETF a Buy, Sell or Hold?

  • The current TCW Flexible Income ETF [FLXR] share price is $38.75. The Score for FLXR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • FLXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FLXR Stock Price Chart

What is TCW Flexible Income ETF's stock price today?

  • The TCW Flexible Income ETF share price today is $38.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FLXR is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FLXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 36.28 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.77 - 39.17) Sell
Bollinger Bands (100): (38.62 - 39.58) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FLXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.8 Sell
20-day SMA: 38.9 Sell
50-day SMA: 39.3 Sell
200-day SMA: 0 Buy
8-day EMA: 38.79 Sell
20-day EMA: 38.91 Sell
50-day EMA: 39.08 Sell
200-day EMA: 6.07 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

TCW Flexible Income ETF Earnings Growth & FLXR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

TCW Flexible Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):